Axon to Participate at Upcoming Investor Conference
Axon to Participate at the Oppenheimer 20th Annual Technology, Internet & Communications Conference
Get Alerts AAXN Hot Sheet
Join SI Premium – FREE
SCOTTSDALE, Ariz., Aug. 4, 2017 /PRNewswire/ -- Axon (Nasdaq: AAXN), the global leader in public safety technology, announced today that members of the Axon management team will participate at the following investor conference:
Oppenheimer 20th Annual Technology, Internet & Communications Conference Date: Wednesday, August 9, 2017 Location: Four Seasons Hotel, Boston, MA Time: 1:45 p.m. ET
The event will be available via live audio webcast and archived replay on Axon's investor relations website at http://investor.axon.com.
About Axon
Axon is a network of devices, apps, and people that helps law enforcement become smarter and safer. Our mission is to protect life. Our technologies give law enforcement the confidence, focus, and time they need to keep their communities safe. Our connected body cameras and evidence-management cloud allow police officers to work effectively and transparently, and our TASER Smart Weapons protect life without taking it.
We work hard for those who put themselves in harm's way for all of us. More than 186,000 lives and countless dollars have been saved with Axon's network of devices, apps and people. Learn more at www.axon.com or by calling (800) 978-2737.
Note to Investors
Please visit http://investor.axon.com, http://axon.com/press, www.twitter.com/axon_us, and https://www.facebook.com/Axon.ProtectLife/ where Axon shares about the company, its financial information and its business.
Visit our Investor Relations Safe Harbor Statement at: http://investor.axon.com/safeHarbor.cfm For investor relations information please contact Arvind Bobra via email at [email protected].
CONTACT: Steve TuttleVice President of Strategic Communications TASER International, Inc.[email protected]
View original content with multimedia:http://www.prnewswire.com/news-releases/axon-to-participate-at-upcoming-investor-conference-300499700.html
SOURCE Axon
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Merck's KEYTRUDA and WELIREG combination for kidney cancer
- Crypto News Today Feels Like a Turning Point While Pepeto Quietly Collects Over $10.2 Million
- Guardant Health receives FDA approval for companion diagnostic test
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share